Yao, Wen, et al. “Treating Relapsed Refractory Acute Myeloid Leukemia With Chidamide, Fludarabine, Cytarabine and Granulocyte-Colony Stimulating Factor With Subsequent Bridging to Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation: Treating Relapsed Refractory Acute Myeloid Leukemia With Chidamide, Fludarabine, Cytarabine and G-CSF”. Mediterranean Journal of Hematology and Infectious Diseases, vol. 14, no. 1, Feb. 2022, p. e2022025, doi:10.4084/MJHID.2022.025.